Hood River Capital Management’s MoonLake Immunotherapeutics MLTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$31.9M	Buy	675,445 +12,462	+2%	+$588K	0.45%	80
2025 Q1	$25.9M	Buy	662,983 +13,393	+2%	+$523K	0.44%	85
2024 Q4	$35.2M	Buy	649,590 +2,928	+0.5%	+$159K	0.52%	77
2024 Q3	$32.6M	Buy	+646,662	New	+$32.6M	0.53%	71